Algernon Pharmaceuticals Inc. C.AGN

CALLING DR. MARK WILLIAMS! CALLING DR. MARK WILLIAMS!

[C10H12N2]

Doc, can you please provide the masses with another BioPub webcast explanation of your mathematical theory of how Ifenprodil has a 65% chance of success at the Phase 2 clinical trial process. I'd like to hear you and the CEO ramble on and on again about how lucky we shareholders are for having a molecule with a good safety history. We are so lucky that ALL shots at scoring a goal have a 65% chance of success. Except the COVID-19 clinical trial for 1 Million $ never got off the ground. Oh! Except the "multi-national" COVID-19 clinical trial primarily conducted in the Second World country of Romania. Damn it we missed two shots at goal with 65% chances of success. But wait...what about the ongoing and neverending Phase 2 clinical trial in Australia and New Zealand? Does that clinical trial for Idiopathic Pulmonary Fibrosis and Chronic Cough also apply to your 65% chance of success mathematical theory as well? I mean it is a Phase 2 clinical trial right. Wait wait wait...something just ain't adding up here. What could it be? Could it be that the only possible way any cockamamie math theory with about 65% chance of success for Ifenprodil actually requires running clinical trials powered for statistical significance? How about a double blind placebo controlled clinical trial. Would that have anything to do with the success of a clinical trial? Yeah, I'd like Dr. Mark Williams to come back to the forefront and explain his math theory once again to shareholders who hung onto that math theory pitched by the CSO and CEO on BioPub and elsewhere on the World Wide Web.